Promoter entities to sell 4.6% stake in Ajanta Pharma via block deal Thursday

Through the sale the entities are looking at raising close to Rs 650 crore.

More To Explore

Lupin Q1 PAT rises 16 pc at Rs 1,417 cr

Lupin Ltd has reported a remarkable sixteen percent surge in profit after tax for the first quarter, showcasing their continued success. The firm experienced considerable